US FDA concerned over potential Novavax myocarditis risk
The Food and Drug Administration voiced concern Friday about myocarditis being potentially linked to the Novavax COVID-19 vaccine, just as experts are to weigh its use in the United States.
Jun 4, 2022
0
41